Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ratner

Showing results (21-30 of 4,048) with videos related to

Pageof 405
Sort By:
Nature Biotechnology|July 13, 2017
FDA deems in vitro data on mutations sufficient to expand cystic fibrosis drug labelMark Ratner
The Medical Clinics of North America|March 19, 2010
Management of the asthmatic attack in childhoodB RATNER
Bio/Technology (Nature Publishing Company)|March 1, 1990
Survey and opinions: barriers to field-testing genetically modified organismsM Ratner
Lancet (London, England)|April 4, 1992
Origin of AIDSH Ratner
Bio/Technology (Nature Publishing Company)|May 1, 1990
Competition in the marketplace. t-PA trials, tribulations, and litigationM Ratner
Skinmed|December 16, 2003
Recurrent squamous cell carcinoma in situ of the fingerDésirée Ratner
Skinmed|December 16, 2003
Lentigo maligna of the cheek: discussion of surgical treatment optionsDésirée Ratner
Drugs of Today (Barcelona, Spain : 1998)|January 1, 2004
Insulin glargine versus NPH insulin in patients with type 1 diabetesRobert Ratner
Endocrinology and Metabolism Clinics of North America|April 12, 2007
Incretin-based therapies for type 2 diabetes: clinical utilityRobert Ratner
Science (New York, N.Y.)|February 5, 1988
Child care dilemmaN Ratner
Pageof 405

Showing results (21-30 of 4,048) with videos related to

Sort By:
Pageof 405
Nature Biotechnology|July 13, 2017
FDA deems in vitro data on mutations sufficient to expand cystic fibrosis drug labelMark Ratner
The Medical Clinics of North America|March 19, 2010
Management of the asthmatic attack in childhoodB RATNER
Bio/Technology (Nature Publishing Company)|March 1, 1990
Survey and opinions: barriers to field-testing genetically modified organismsM Ratner
Lancet (London, England)|April 4, 1992
Origin of AIDSH Ratner
Bio/Technology (Nature Publishing Company)|May 1, 1990
Competition in the marketplace. t-PA trials, tribulations, and litigationM Ratner
Skinmed|December 16, 2003
Recurrent squamous cell carcinoma in situ of the fingerDésirée Ratner
Skinmed|December 16, 2003
Lentigo maligna of the cheek: discussion of surgical treatment optionsDésirée Ratner
Drugs of Today (Barcelona, Spain : 1998)|January 1, 2004
Insulin glargine versus NPH insulin in patients with type 1 diabetesRobert Ratner
Endocrinology and Metabolism Clinics of North America|April 12, 2007
Incretin-based therapies for type 2 diabetes: clinical utilityRobert Ratner
Science (New York, N.Y.)|February 5, 1988
Child care dilemmaN Ratner
Pageof 405